SCHEMBL16508205

SCHEMBL16508205

CC(=O)Nc1ccc2cnccc2c1S(=O)(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 3/20 0.42
MAPT P10636 4/20 0.42
KDM4E B2RXH2 3/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 1/20 0.42
CHUK O15111 1/20 0.41
CASP6 P55212 1/20 0.40
GALK1 P51570 1/20 0.39
ATM Q13315 1/20 0.39
ERN1 O75460 1/20 0.39
KMT2A Q03164 3/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
DYRK1A Q13627 2/20 0.37
CLK1 P49759 1/20 0.37
CLK2 P49760 1/20 0.37
CLK3 P49761 1/20 0.37
CDK5 Q00535 1/20 0.37
CDK5R1 Q15078 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
DYRK1B Q9Y463 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5173798 0.80 ALDH1A1 (0.54) MAPTKDM4EALDH1A1HPGDCASP6
SCHEMBL16508198 0.76 CASP6 (0.44) MAPTKDM4EALDH1A1HPGDCHUK
SCHEMBL4023574 0.75 MAPT (0.62) MAPTKDM4EALDH1A1GALK1ATM
SCHEMBL16508209 0.73 IMPDH2 (0.53) IMPDH2MAPTKDM4EALDH1A1CASP6
SCHEMBL5657826 0.72 RXFP1 (0.45) MAPTKDM4EALDH1A1HPGDCHUK
SCHEMBL4026288 0.70 IMPDH2 (0.49) IMPDH2MAPTKDM4EALDH1A1CHUK
SCHEMBL20072220 0.70 ALDH1A1 (0.47) IMPDH2MAPTKDM4EALDH1A1CHUK
SCHEMBL1637363 0.69 ALDH1A1 (0.55) IMPDH2MAPTALDH1A1HPGDCHUK
SCHEMBL30418934 0.69 ALDH1A1 (0.55) IMPDH2MAPTALDH1A1HPGDCHUK
SCHEMBL4019913 0.69 CHUK (0.45) MAPTKDM4EALDH1A1CHUKGALK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110294789-A1 COMPOUNDS FOR RHO KINASE INHIBITION AND FOR IMPROVING LEARNING AND MEMORY AMNESTIX, INC. 2011-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294789-A1 COMPOUNDS FOR RHO KINASE INHIBITION AND FOR IMPROVING LEARNING AND MEMORY ROCK1, IRAK1, ROCK2 IMPDH2 2141/4885MAPT 704/4885KDM4E 590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.